The TrialMaster Ph I application allows you to capitalize on the benefits of EDC without overhauling and disrupting your Phase I clinical work flow processes. Unlike other applications, TrialMaster Ph I adapts to your processes allowing you to increase productivity, reduce trial time and improve data quality while reducing overall costs. Two characteristics in Phase I trials that typically don’t lend themselves well to deploying EDC are that Phase I studies tend to be very short in nature with a minimal amount of patients and data. And the second characteristic is that the site users never truly get a chance to get comfortable with the EDC solution they use because they don’t access the system that often and if they do, it is only for a very short amount of time. With OmniComm’s TrialMaster the following advantages allow EDC to be successful in Phase I studies.
|
